Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-6536
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies ; volume:9 ; number:2 ; day:18 ; month:9 ; year:2020 ; pages:317-333 ; date:12.2020
Neurology and Therapy ; 9, Heft 2 (18.9.2020), 317-333, 12.2020
- Urheber
-
Koike, Haruki
Katsuno, Masahisa
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40120-020-00210-7
- URN
-
urn:nbn:de:101:1-2020121519402709564179
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Koike, Haruki
- Katsuno, Masahisa
- SpringerLink (Online service)
Ähnliche Objekte (12)
Current Disease-Modifying Therapies in Multiple Sclerosis
Hereditary transthyretin amyloidosis overview
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
Type-1 spinal muscular atrophy cohort before and after disease-modifying therapies
Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
Disease-Modifying Therapies for Alzheimer’s Disease: More Questions than Answers
Multidisciplinary Approaches for Transthyretin Amyloidosis
Sex differences in transthyretin cardiac amyloidosis
Hereditary transthyretin amyloidosis: a case report
Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
Current Disease-Modifying Therapies in Multiple Sclerosis
Hereditary transthyretin amyloidosis overview
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
Type-1 spinal muscular atrophy cohort before and after disease-modifying therapies
Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
Disease-Modifying Therapies for Alzheimer’s Disease: More Questions than Answers
Multidisciplinary Approaches for Transthyretin Amyloidosis
Sex differences in transthyretin cardiac amyloidosis
Hereditary transthyretin amyloidosis: a case report
Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register
The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations
Current Disease-Modifying Therapies in Multiple Sclerosis
Hereditary transthyretin amyloidosis overview
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
Type-1 spinal muscular atrophy cohort before and after disease-modifying therapies
Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
Disease-Modifying Therapies for Alzheimer’s Disease: More Questions than Answers
Multidisciplinary Approaches for Transthyretin Amyloidosis
Sex differences in transthyretin cardiac amyloidosis
Hereditary transthyretin amyloidosis: a case report
Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
Injectable Versus Oral First-Line Disease-Modifying Therapies: Results from the Italian MS Register